Attend the FierceBiotech Executive Breakfast at JPM
Join us on January 14th at the Fairmont San Francisco. Register today.
NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.
The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.
The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.